Showing 1 - 10 of 176
Persistent link: https://www.econbiz.de/10008527190
Persistent link: https://www.econbiz.de/10011938723
Persistent link: https://www.econbiz.de/10014317907
Private agents make large contributions to networks of conserved land, but little is known about how private agents' decisions might be altered by government actions. This paper explores the impact of public conservation and public policy on the quantity and configuration of private land...
Persistent link: https://www.econbiz.de/10005152748
The authors evaluate the impact of an educational intervention, in which a Kenyan non-governmental organization distributes school uniforms to children in poor communities. The Nongovernmental organization (NGO) used a lottery to determine who would receive uniforms. Although compliance with the...
Persistent link: https://www.econbiz.de/10012248166
Time use researchers working in least developed countries (LDCs) face difficulties collecting data from illiterate populations who may conceptualize time differently than those in industrialized countries. We identify existing gaps in time use data collection methods and discuss two novel,...
Persistent link: https://www.econbiz.de/10010848415
This article discusses the evolving field of pharmacogenomics, which is the science of using genomic markers to predict drug response, and how it may impact the future costs, risks and returns to pharmaceutical research and development (R&D). We uncover a number of factors and issues that are...
Persistent link: https://www.econbiz.de/10010849010
Persistent link: https://www.econbiz.de/10010987551
Corporate voluntary climate programs have had limited evaluation. The self-selection of participants—an essential element of such initiatives—poses challenges to researchers because the decision to participate may not be random and may be correlated with outcomes. This study aims to gage the...
Persistent link: https://www.econbiz.de/10011047111
This article discusses the evolving field of pharmacogenomics, which is the science of using genomic markers to predict drug response, and how it may impact the future costs, risks and returns to pharmaceutical research and development (R&D). We uncover a number of factors and issues that are...
Persistent link: https://www.econbiz.de/10004993640